Back to HHLR Advisors, Ltd. HHLR Advisors, Ltd.

KNSAKNSA

Showing 3 of 4 quarters

Position history for HHLR Advisors, Ltd.HHLR Advisors, Ltd.'s holdings in Kiniksa Pharmaceuticals International, plc

No. HHLR Advisors exited its KNSA (Kiniksa Pharmaceuticals International) position in Q1 2025. Its Q4 2024 13F listed 1,582,635 shares worth $31.3M. HHLR Advisors already held KNSA in its Q2 2024 13F, the earliest on record, and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$39.6M

Total Shares Change

-1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$22.21
0
2024-Q4
Unchanged
1.6M
0.0%
$31.3M1.1%$19.78
0
2024-Q3
Decreased
1.6M
-49.7%
$39.6M0.9%$24.99
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used